253 related articles for article (PubMed ID: 21296654)
1. Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis.
Yadev NP; Murdoch C; Saville SP; Thornhill MH
Microb Pathog; 2011 Jun; 50(6):278-85. PubMed ID: 21296654
[TBL] [Abstract][Full Text] [Related]
2. Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis.
Tardif F; Goulet JP; Zakrazewski A; Chauvin P; Rouabhia M
Med Sci Monit; 2004 Aug; 10(8):BR239-49. PubMed ID: 15277983
[TBL] [Abstract][Full Text] [Related]
3. CX3CL1 expression induced by Candida albicans in oral fibroblasts.
Ohta K; Nishi H; Fukui A; Shigeishi H; Takechi M; Kamata N
FEMS Immunol Med Microbiol; 2010 Nov; 60(2):179-85. PubMed ID: 20880200
[TBL] [Abstract][Full Text] [Related]
4. Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium.
Silva S; Henriques M; Hayes A; Oliveira R; Azeredo J; Williams DW
J Oral Pathol Med; 2011 May; 40(5):421-7. PubMed ID: 21158929
[TBL] [Abstract][Full Text] [Related]
5. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans.
Claveau I; Mostefaoui Y; Rouabhia M
Matrix Biol; 2004 Nov; 23(7):477-86. PubMed ID: 15579314
[TBL] [Abstract][Full Text] [Related]
6. In vitro analyses of tissue structure and interleukin-1beta expression and production by human oral mucosa in response to Candida albicans infections.
Mostefaoui Y; Claveau I; Rouabhia M
Cytokine; 2004 Feb; 25(4):162-71. PubMed ID: 15162833
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models.
Li L; Kashleva H; Dongari-Bagtzoglou A
Microb Pathog; 2007 Apr; 42(4):138-47. PubMed ID: 17306958
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Candida albicans infection of an in vitro oral epithelial model using confocal laser scanning microscopy.
Malic S; Hill KE; Ralphs JR; Hayes A; Thomas DW; Potts AJ; Williams DW
Oral Microbiol Immunol; 2007 Jun; 22(3):188-94. PubMed ID: 17488445
[TBL] [Abstract][Full Text] [Related]
9. Oral epithelium-Candida glabrata interactions in vitro.
Li L; Dongari-Bagtzoglou A
Oral Microbiol Immunol; 2007 Jun; 22(3):182-7. PubMed ID: 17488444
[TBL] [Abstract][Full Text] [Related]
10. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis.
Vultaggio A; Lombardelli L; Giudizi MG; Biagiotti R; Mazzinghi B; Scaletti C; Mazzetti M; Livi C; Leoncini F; Romagnani S; Maggi E; Piccinni MP
Microbes Infect; 2008 Feb; 10(2):166-74. PubMed ID: 18249024
[TBL] [Abstract][Full Text] [Related]
11. [Experimental oral candidiasis in healthy and immunocompromised BALB/c mice].
Karaman M; Kiray M; Bayrakal V; Bağrıyanık HA; Yılmaz O; Bahar IH
Mikrobiyol Bul; 2011 Apr; 45(2):336-43. PubMed ID: 21644077
[TBL] [Abstract][Full Text] [Related]
12. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis.
Bartie KL; Williams DW; Wilson MJ; Potts AJ; Lewis MA
Oral Microbiol Immunol; 2004 Oct; 19(5):293-6. PubMed ID: 15327640
[TBL] [Abstract][Full Text] [Related]
13. Tissue engineering of oral dysplasia.
Gaballah K; Costea DE; Hills A; Gollin SM; Harrison P; Partridge M
J Pathol; 2008 Jul; 215(3):280-9. PubMed ID: 18484684
[TBL] [Abstract][Full Text] [Related]
14. Tissue-engineered oral mucosa.
Moharamzadeh K; Colley H; Murdoch C; Hearnden V; Chai WL; Brook IM; Thornhill MH; Macneil S
J Dent Res; 2012 Jul; 91(7):642-50. PubMed ID: 22266525
[TBL] [Abstract][Full Text] [Related]
15. IL-1alpha, IL-1ra and IL-8 are differentially induced by Candida in experimental oral candidiasis.
Jayatilake JA; Samaranayake LP; Lu Q; Jin LJ
Oral Dis; 2007 Jul; 13(4):426-33. PubMed ID: 17577331
[TBL] [Abstract][Full Text] [Related]
16. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia for the study of host-pathogen interactions.
Schaller M; Weindl G
Methods Mol Biol; 2009; 470():327-45. PubMed ID: 19089393
[TBL] [Abstract][Full Text] [Related]
17. Oral mucosal cell response to Candida albicans in transgenic mice expressing HIV-1.
de Repentigny L; Lewandowski D; Aumont F; Hanna Z; Jolicoeur P
Methods Mol Biol; 2009; 470():359-68. PubMed ID: 19089395
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel three-dimensional in vitro model of oral Candida infection.
Dongari-Bagtzoglou A; Kashleva H
Microb Pathog; 2006 Jun; 40(6):271-8. PubMed ID: 16626928
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a three-dimensional mucosal equivalent: similarities and differences with native oral mucosa.
Tra WM; van Neck JW; Hovius SE; van Osch GJ; Perez-Amodio S
Cells Tissues Organs; 2012; 195(3):185-96. PubMed ID: 21494020
[TBL] [Abstract][Full Text] [Related]
20. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.
Samaranayake YH; Wu PC; Samaranayake LP; Ho PL
J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
